关注
Jaime R Merchan
Jaime R Merchan
Tenured Professor of Medicine, University of Miami Miller School of Medicine
在 med.miami.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
SE Maynard, JY Min, J Merchan, KH Lim, J Li, S Mondal, TA Libermann, ...
The Journal of clinical investigation 111 (5), 649-658, 2003
51122003
Pazopanib versus sunitinib in metastatic renal-cell carcinoma
RJ Motzer, TE Hutson, D Cella, J Reeves, R Hawkins, J Guo, P Nathan, ...
New England Journal of Medicine 369 (8), 722-731, 2013
21152013
Sunitinib in patients with metastatic renal cell carcinoma
RJ Motzer, BI Rini, RM Bukowski, BD Curti, DJ George, GR Hudes, ...
Jama 295 (21), 2516-2524, 2006
16192006
Lenvatinib plus pembrolizumab or everolimus for advanced renal cell carcinoma
R Motzer, B Alekseev, SY Rha, C Porta, M Eto, T Powles, V Grünwald, ...
New England Journal of Medicine 384 (14), 1289-1300, 2021
13222021
Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial
BA Wilky, MM Trucco, TK Subhawong, V Florou, W Park, D Kwon, ...
The lancet oncology 20 (6), 837-848, 2019
3222019
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
PJ Hosein, J Macintyre, C Kawamura, JC Maldonado, V Ernani, ...
BMC cancer 12, 1-7, 2012
2622012
A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials
BC Leibovich, JC Cheville, CM Lohse, H Zincke, I Frank, ED Kwon, ...
The Journal of urology 174 (5), 1759-1763, 2005
2552005
Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis
TK Choueiri, TM Bauer, KP Papadopoulos, ER Plimack, JR Merchan, ...
Nature medicine 27 (5), 802-805, 2021
1982021
Enfortumab vedotin plus pembrolizumab in previously untreated advanced urothelial cancer
CJ Hoimes, TW Flaig, MI Milowsky, TW Friedlander, MA Bilen, S Gupta, ...
Journal of clinical oncology 41 (1), 22-31, 2023
1562023
A phase II trial of nab-Paclitaxel as second-line therapy in patients with advanced pancreatic cancer
PJ Hosein, G de Lima Lopes Jr, VH Pastorini, C Gomez, J Macintyre, ...
American journal of clinical oncology 36 (2), 151-156, 2013
1382013
Antiangiogenic activity of 2-deoxy-D-glucose
JR Merchan, K Kovács, JW Railsback, M Kurtoglu, Y Jing, Y Piña, N Gao, ...
PloS one 5 (10), e13699, 2010
1242010
Study EV-103: preliminary durability results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma.
JE Rosenberg, TW Flaig, TW Friedlander, MI Milowsky, S Srinivas, ...
Journal of Clinical Oncology 38 (6_suppl), 441-441, 2020
1232020
Percutaneous image-guided irreversible electroporation for the treatment of unresectable, locally advanced pancreatic adenocarcinoma
G Narayanan, PJ Hosein, IC Beulaygue, T Froud, HJ Scheffer, SR Venkat, ...
Journal of Vascular and Interventional Radiology 28 (3), 342-348, 2017
1222017
Randomized, open-label, phase III trial of pazopanib versus sunitinib in first-line treatment of patients with metastatic renal cell carcinoma (mRCC): results of the COMPARZ trial
R Motzer, TE Hutson, J Reeves, R Hawkins, J Guo, P Nathan, M Staehler, ...
Annals of Oncology 23, ixe13, 2012
1192012
EUS visualization and direct celiac ganglia neurolysis predicts better pain relief in patients with pancreatic malignancy (with video)
G Ascunce, A Ribeiro, I Reis, C Rocha-Lima, D Sleeman, J Merchan, ...
Gastrointestinal endoscopy 73 (2), 267-274, 2011
1172011
Renal cancer: molecular mechanisms and newer therapeutic options
SA Karumanchi, J Merchan, VP Sukhatme
Current opinion in nephrology and hypertension 11 (1), 37-42, 2002
1172002
A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma
SN Markovic, VJ Suman, RA Rao, JN Ingle, JS Kaur, LA Erickson, ...
American journal of clinical oncology 30 (3), 303-309, 2007
1122007
Increased endothelial uptake of paclitaxel as a potential mechanism for its antiangiogenic effects: potentiation by Cox‐2 inhibition
JR Merchan, DR Jayaram, JG Supko, X He, GJ Bubley, VP Sukhatme
International journal of cancer 113 (3), 490-498, 2005
1072005
Phase I/II trial of CCI-779 and bevacizumab in stage IV renal cell carcinoma: phase I safety and activity results
JR Merchan, G Liu, T Fitch, J Picus, R Qin, HC Pitot, W Maples, ...
Journal of Clinical Oncology 25 (18_suppl), 5034-5034, 2007
992007
Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma
N Dempsey, JC Maldonado, A Loaiza-Bonilla, M Velez, L Carcas, ...
Pancreatology 15 (6), 667-673, 2015
892015
系统目前无法执行此操作,请稍后再试。
文章 1–20